Bret has worked in quantitative analytics for over 12 years in a variety of roles, starting his career as a consulting actuary before moving into marketing analytics within the pharmaceutical industry. During his career, Bret has focused on providing strategic business and marketing insights using data and predictive modeling as the backbone. Bret has worked within a number of industries outside healthcare as well, including oil and gas, non-profit, finance, and mining/exploration.
Bret has a BS in mathematics from Penn State University and an MBA in marketing from Villanova University. Bret currently works at Villanova University as an adjunct professor in the management department. He also serves as an Associate of the Society of Actuaries.
Follow Bret Baker:
Bret's Articles, Blog Posts, Webinars and More
Beyond Price Wars: Using Copay Programs to Drive Adoption
The use of co-pay or coupon cards are typically considered for prescription drugs farther along in their lifecycle, when there are either new entrants in the category or when generics of less-expensive biosimilar products become available. A logical thought in the latter case is “all else being equal, a patient and prescriber will prefer the branded product.”
It is critical to move away from an ad hoc approach incorporating email into your campaign strategy, and to take a more analytic approach to the frequency, content, cadence, and targeting of your overall email communication.